FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016037638> ?p ?o ?g. }

• W2016037638 endingPage "2232" @default.
• W2016037638 startingPage "2226" @default.
• W2016037638 abstract "Summary The transient receptor potential vanilloid channel 1 (TRPV1) receptor agonist olvanil inhibits neuronal activity in the trigeminocervical complex acting on vanilloid and cannabinoid receptor systems. The transient receptor potential vanilloid channel 1 (TRPV1) is a nociceptive transducer located on nociceptive neurons. TRPV1 channels located on peripheral neurons mainly transduce the sense of heat and are also activated by low pH or capsaicin. The role of centrally located TRPV1 channels is not fully understood. Likewise their importance in pain syndromes of central origin, such as migraine, is not known. Experimental data suggest a relationship to migraine. However, experimental studies with TRPV1 receptor antagonists indicate that the receptor may not be a useful target for new acute migraine treatments. Any potential role for the receptor in the chronification of migraine has not been investigated. The present study aimed at analyzing the use of the TRPV1 channel as a target to desensitize trigeminal neurons and thereby inhibit neuronal activity in the trigeminocervical complex. The TRPV1 receptor agonist olvanil was used for desensitization because, as compared with capsaicin, it is non-noxious and lacks capsaicin’s pungency and CGRP release potential. We further investigated a possible effect of olvanil on cannabinoid (CB1) receptors, as an interaction between both receptor systems has been described previously. The results show that olvanil dose-dependently inhibited spontaneous and stimulus-induced activity within the trigeminocervical complex, whereas it had no effect on CSD susceptibility. We further demonstrated that the inhibiting effect of olvanil is mediated by vanilloid and cannabinoid receptor systems, thereby using the synergistic effects this dual mechanism offers. Curiously, TRPV1 receptor agonism may have anti-nociceptive properties through central mechanisms that would be of considerable interest to elucidate." @default.
• W2016037638 created "2016-06-24" @default.
• W2016037638 creator A5008504650 @default.
• W2016037638 creator A5030183123 @default.
• W2016037638 creator A5041491240 @default.
• W2016037638 creator A5055812587 @default.
• W2016037638 creator A5058994427 @default.
• W2016037638 creator A5083988616 @default.
• W2016037638 date "2012-11-01" @default.
• W2016037638 modified "2023-10-07" @default.
• W2016037638 title "Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system" @default.
• W2016037638 cites W1492591187 @default.
• W2016037638 cites W1511198581 @default.
• W2016037638 cites W1883044208 @default.
• W2016037638 cites W1923918181 @default.
• W2016037638 cites W1964358846 @default.
• W2016037638 cites W1969061731 @default.
• W2016037638 cites W1970559021 @default.
• W2016037638 cites W1970745458 @default.
• W2016037638 cites W1973662774 @default.
• W2016037638 cites W1978789346 @default.
• W2016037638 cites W1994528071 @default.
• W2016037638 cites W1996634599 @default.
• W2016037638 cites W2003706636 @default.
• W2016037638 cites W2007034094 @default.
• W2016037638 cites W2007400067 @default.
• W2016037638 cites W2010086382 @default.
• W2016037638 cites W2012864750 @default.
• W2016037638 cites W2019969188 @default.
• W2016037638 cites W2025077832 @default.
• W2016037638 cites W2029539224 @default.
• W2016037638 cites W2030135937 @default.
• W2016037638 cites W2030926565 @default.
• W2016037638 cites W2038098935 @default.
• W2016037638 cites W2040824334 @default.
• W2016037638 cites W2042867444 @default.
• W2016037638 cites W2044632947 @default.
• W2016037638 cites W2045858354 @default.
• W2016037638 cites W2060277249 @default.
• W2016037638 cites W2063102563 @default.
• W2016037638 cites W2064441047 @default.
• W2016037638 cites W2066080151 @default.
• W2016037638 cites W2068748307 @default.
• W2016037638 cites W2072730289 @default.
• W2016037638 cites W2075715972 @default.
• W2016037638 cites W2078980646 @default.
• W2016037638 cites W2080341798 @default.
• W2016037638 cites W2087070254 @default.
• W2016037638 cites W2088475044 @default.
• W2016037638 cites W2090560354 @default.
• W2016037638 cites W2100585655 @default.
• W2016037638 cites W2107705149 @default.
• W2016037638 cites W2120030331 @default.
• W2016037638 cites W2123673561 @default.
• W2016037638 cites W2129104258 @default.
• W2016037638 cites W2143970752 @default.
• W2016037638 cites W2161954110 @default.
• W2016037638 cites W2333010170 @default.
• W2016037638 cites W2597593464 @default.
• W2016037638 doi "https://doi.org/10.1016/j.pain.2012.07.006" @default.
• W2016037638 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22902197" @default.
• W2016037638 hasPublicationYear "2012" @default.
• W2016037638 type Work @default.
• W2016037638 sameAs 2016037638 @default.
• W2016037638 citedByCount "15" @default.
• W2016037638 countsByYear W20160376382013 @default.
• W2016037638 countsByYear W20160376382014 @default.
• W2016037638 countsByYear W20160376382015 @default.
• W2016037638 countsByYear W20160376382016 @default.
• W2016037638 countsByYear W20160376382017 @default.
• W2016037638 countsByYear W20160376382020 @default.
• W2016037638 countsByYear W20160376382021 @default.
• W2016037638 countsByYear W20160376382022 @default.
• W2016037638 countsByYear W20160376382023 @default.
• W2016037638 crossrefType "journal-article" @default.
• W2016037638 hasAuthorship W2016037638A5008504650 @default.
• W2016037638 hasAuthorship W2016037638A5030183123 @default.
• W2016037638 hasAuthorship W2016037638A5041491240 @default.
• W2016037638 hasAuthorship W2016037638A5055812587 @default.
• W2016037638 hasAuthorship W2016037638A5058994427 @default.
• W2016037638 hasAuthorship W2016037638A5083988616 @default.
• W2016037638 hasConcept C126322002 @default.
• W2016037638 hasConcept C148001335 @default.
• W2016037638 hasConcept C15490471 @default.
• W2016037638 hasConcept C155164980 @default.
• W2016037638 hasConcept C160145004 @default.
• W2016037638 hasConcept C169760540 @default.
• W2016037638 hasConcept C170493617 @default.
• W2016037638 hasConcept C172659308 @default.
• W2016037638 hasConcept C2778938600 @default.
• W2016037638 hasConcept C2780051329 @default.
• W2016037638 hasConcept C2780071552 @default.
• W2016037638 hasConcept C2780871563 @default.
• W2016037638 hasConcept C71924100 @default.
• W2016037638 hasConcept C86803240 @default.
• W2016037638 hasConcept C98274493 @default.
• W2016037638 hasConceptScore W2016037638C126322002 @default.
• W2016037638 hasConceptScore W2016037638C148001335 @default.

• next